+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

Idiopathic Pulmonary Fibrosis Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis Treatment Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 160 Pages
  • Global
From
Emphysema Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Emphysema Treatment Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 160 Pages
  • Global
From
Cystic Fibrosis Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cystic Fibrosis Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
Asthma Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Asthma Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
Acute Respiratory Syndrome Market Report and Forecast 2023-2031 - Product Thumbnail Image

Acute Respiratory Syndrome Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Bronchial Spasms Treatment Market - Global Forecast Report 2023-2031 - Product Thumbnail Image

Bronchial Spasms Treatment Market - Global Forecast Report 2023-2031

  • Report
  • March 2023
  • 147 Pages
  • Global
From
BREO Ellipta Drugs Market - Global Forecast Report 2023-2031 - Product Thumbnail Image

BREO Ellipta Drugs Market - Global Forecast Report 2023-2031

  • Report
  • March 2023
  • 147 Pages
  • Global
From
Dry Powder Inhaler Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies - Product Thumbnail Image

Dry Powder Inhaler Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

  • Report
  • November 2023
  • 135 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update

  • Report
  • June 2023
  • 430 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis (IPF) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis (IPF) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • April 2023
  • 72 Pages
  • Global
From
Respiratory Syncytial Virus Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Respiratory Syncytial Virus Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • March 2023
  • 69 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease (COPD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease (COPD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • January 2023
  • 90 Pages
  • Global
From
Asthma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Asthma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • October 2022
  • 81 Pages
  • Global
From
Hospital Acquired Pneumonia Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Hospital Acquired Pneumonia Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • September 2022
  • 76 Pages
  • Global
From
Bronchiectasis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Bronchiectasis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • July 2022
  • 71 Pages
  • Global
From
Alpha-1 Antitrypsin Deficiency Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies & Forecast, 2021-2031 - Product Thumbnail Image

Alpha-1 Antitrypsin Deficiency Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies & Forecast, 2021-2031

  • Drug Pipelines
  • April 2022
  • 54 Pages
  • Global
From
Sarcopenia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update - Product Thumbnail Image

Sarcopenia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update

  • Report
  • March 2022
  • 58 Pages
  • Global
From
Pulmonary Fibrosis - Global Clinical Trials Review, 2022 - Product Thumbnail Image

Pulmonary Fibrosis - Global Clinical Trials Review, 2022

  • Clinical Trials
  • January 2022
  • 442 Pages
  • Global
From
Obstructive Sleep Apnea - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Obstructive Sleep Apnea - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • September 2021
  • 250 Pages
  • Global
From
Asthma - Epidemiology Forecast to 2029 - Product Thumbnail Image

Asthma - Epidemiology Forecast to 2029

  • Report
  • November 2020
  • 36 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more